News Story: Full Text
Sponsored By
Orbus Therapeutics Inc Clinical Trial for Recurrent Anaplastic Astrocytomas
Please Click On The Above Banner For More Details
Braintumor Website

 

Durable Responses Observed in Recurrent High Grade Glioma (rHGG) with Toca 511 & Toca FC Treatment

Al's Comment:

 This is a presentation about the Toca 511 / Toca FC  trial.   There are 6 long term survivors (4 GBM, 2 AA), all of whom had a complete response,  And once they achieve a complete response, NONE had a recurrence.  We never use the word "cured" when talking about a GBM, but having a clear scan for over 3 years makes us think it is possible a few of these patients may have been cured.  It is only a small  % at this time - 43% have some benefit from the treatment, and 20% have a significant response.  Hopefully it will only get better and this may lead to a major breakthrough.

The Musella Foundation was an early supporter of this research (and they acknowledge us on the presentation:)


Posted on: 10/28/2017

Durable Responses Observed in Recurrent High Grade Glioma (rHGG) with Toca 511 & Toca FC Treatment

Editor's Note:

 This is a presentation about the Toca 511 / Toca FC  trial.   There are 6 long term survivors (4 GBM, 2 AA), ALL of whom had a complete response,  And once they achieve a complete response, NONE had a recurrence.  We never use the word "cured" when talking about a GBM, but having a clear scan for over 3 years makes us think it is possible a few of these patients may have been cured.  It is only a small  % at this time - 43% have some benefit from the treatment, and 20% have a significant response.  Hopefully it will only get better and this may lead to a major breakthrough.

The Musella Foundation was an early supporter of this research (and they acknowledge us on the presentation:)

(The link is to a .pdf file.  The free adobe reader might be needed to view it)

 


 

 


Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites



Musella Foundation For Brain Tumor Research & Information, Inc